Tag:
BioWa
Latest Headlines
Latest Headlines
Sanofi, BioWa ink licensing deal
BioWa and Sanofi-Aventis have signed a deal in which Sanofi gains non-exclusive rights to BioWa's Potelligent technology platform for the research, development and commercialization of their antibody
